bisoprolol has been researched along with sq-11725 in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Irvine, NA; Lipworth, BJ; McDevitt, DG | 1 |
| Lipworth, BJ; McDevitt, DG; McFarlane, LC; Wheeldon, NM | 1 |
| Lipworth, BJ; McDevitt, DG; Wheeldon, NM | 1 |
| Kurosawa, H; Taira, N; Yanagisawa, T | 1 |
| Abdelmawla, AH; Bradshaw, CM; Langley, RW; Szabadi, E | 2 |
| Baldini, K; Cecchi, F; Coppini, R; Ferrantini, C; Grifoni, C; Maron, BJ; Maron, MS; Nistri, S; Olivotto, I; Sgalambro, A | 1 |
| Agha, NH; Baker, FL; Bigley, AB; Bollard, CM; Bond, RA; Graff, RM; Katsanis, E; Kunz, HE; Laughlin, M; LaVoy, EC; Markofski, MM; Simpson, RJ | 1 |
| Jacobsen, SJ; Kalantar-Zadeh, K; Kovesdy, CP; Lee, MS; Neyer, JR; Shaw, SF; Shi, J; Sim, JJ; Zhou, H | 1 |
| Agha, NH; Azadan, RJ; Baker, FL; Kunz, HE; Ledoux, TA; Mylabathula, PL; O'Connor, DP; Pedlar, CR; Simpson, RJ | 1 |
| Ballotari, M; Gottardo, R; Tagliaro, F; Taus, F; Utzeri, C | 1 |
1 review(s) available for bisoprolol and sq-11725
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
6 trial(s) available for bisoprolol and sq-11725
| Article | Year |
|---|---|
A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisoprolol; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Propanolamines; Single-Blind Method; Statistics as Topic; Tremor | 1991 |
Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Basal Metabolism; Bisoprolol; Blood Glucose; Fatty Acids, Nonesterified; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Male; Nadolol; Phenethylamines; Potassium; Single-Blind Method | 1994 |
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Bisoprolol; Drug Interactions; Hemodynamics; Humans; Male; Myocardial Contraction; Nadolol; Phenethylamines; Tremor | 1994 |
Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Blood Pressure; Double-Blind Method; Hand; Heart Rate; Humans; Male; Nadolol; Norepinephrine; Placebos; Vasoconstriction | 1998 |
Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Bisoprolol; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Hand; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Nadolol; Phenylephrine; Placebos; Vasodilation; Veins | 2001 |
β
Topics: Adult; Bisoprolol; Catecholamines; CD8-Positive T-Lymphocytes; Cross-Over Studies; Double-Blind Method; Exercise; Female; Healthy Volunteers; Humans; Killer Cells, Natural; Lymphocyte Activation; Male; Monocytes; Nadolol; Receptors, Adrenergic, beta-2; Signal Transduction | 2018 |
17 other study(ies) available for bisoprolol and sq-11725
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Biphasic antagonisms by beta-blockers against positive inotropic response through beta1-adrenoceptors in isolated canine right ventricular muscles: possible involvement of two beta 1-adrenoceptor subtypes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bisoprolol; Dogs; Dose-Response Relationship, Drug; Ethanolamines; Female; Isoproterenol; Male; Myocardial Contraction; Myocardium; Nadolol; Papillary Muscles; Receptors, Adrenergic, beta-1; Stimulation, Chemical | 1996 |
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Cohort Studies; Confidence Intervals; Echocardiography, Stress; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nadolol; Primary Prevention; Proportional Hazards Models; Prospective Studies; Risk Assessment; Treatment Outcome; Ventricular Outflow Obstruction; Young Adult | 2012 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Death; Cohort Studies; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Mortality; Nadolol; Proportional Hazards Models; Propranolol; Protective Factors; Renal Dialysis; Retrospective Studies; Risk; Risk Factors | 2021 |
The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Bicycling; Bisoprolol; Cross-Over Studies; Erythropoietin; Female; Humans; Male; Nadolol; Physical Endurance; Running; Up-Regulation | 2021 |
Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium; Calcium Channel Blockers; Chromatography, Liquid; Hair Analysis; Humans; Labetalol; Metoprolol; Nadolol; Nebivolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry | 2022 |